FMP
Datasets

Blogs by Danny Green

blog post title

Centrica plc (CPYYY)'s Financial Performance and Market Valuation

CPYYY's adjusted earnings per share (EPS) of approximately $0.60 beat analyst expectations, indicating resilient profitability amid market challenges. However, the statutory EPS was a loss of approxi...

blog post title

Rio Tinto Group (NYSE:RIO) Quarterly Earnings Overview

Rio Tinto Group (NYSE:RIO) is a leading global mining company, known for its extensive operations in the extraction and ...

blog post title

PPL Corporation (NYSE:PPL) Earnings Preview: What to Expect

PPL Corporation (NYSE:PPL) is set to release its quarterly earnings on February 20, 2026. The company, a major player in...

blog post title

Comfort Systems USA, Inc. (NYSE: FIX) Sees Rising Analyst Optimism

Comfort Systems USA, Inc. (NYSE: FIX) operates in the mechanical and electrical services industry, providing essential s...

blog post title

BAE Systems (OTC:BAESY) Earnings Report Highlights

BAE Systems (OTC:BAESY) is a leading defense company based in the UK, known for manufacturing military equipment such as...

blog post title

CoinShares International Limited (CNSRF) Earnings Report Highlights

CoinShares International Limited, trading under the symbol CNSRF on the Nasdaq Stockholm and US OTCQX, is a global asset...

blog post title

AMN Healthcare Services (NYSE:AMN) Earnings Preview: Key Financial Insights

AMN Healthcare Services (NYSE:AMN) is a prominent player in the healthcare staffing industry, providing workforce soluti...

blog post title

Alibaba Group Holding Limited (NYSE:BABA) Quarterly Earnings Preview

Alibaba Group Holding Limited (NYSE:BABA) is preparing to release its quarterly earnings on February 19, 2026. Analysts ...

blog post title

Allegion plc (NYSE:ALLE) Earnings Report Analysis

Allegion plc (NYSE:ALLE) is a leading global provider of security products and solutions. The company operates in the Za...

blog post title

Krystal Biotech, Inc. (NASDAQ: KRYS) Shows Promising Financial and Clinical Progress

Krystal Biotech, Inc. (NASDAQ: KRYS) is a clinical-stage biotechnology company that focuses on developing gene therapies...